| Title : Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients - Brisson_2002_Pharmacogenet_12_313 |
| Author(s) : Brisson D , Ledoux K , Bosse Y , St-Pierre J , Julien P , Perron P , Hudson TJ , Vohl MC , Gaudet D |
| Ref : Pharmacogenetics , 12 :313 , 2002 |
| Abstract : Brisson_2002_Pharmacogenet_12_313 |
| ESTHER : Brisson_2002_Pharmacogenet_12_313 |
| PubMedSearch : Brisson_2002_Pharmacogenet_12_313 |
| PubMedID: 12042669 |
Brisson D, Ledoux K, Bosse Y, St-Pierre J, Julien P, Perron P, Hudson TJ, Vohl MC, Gaudet D (2002)
Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients
Pharmacogenetics
12 :313
Brisson D, Ledoux K, Bosse Y, St-Pierre J, Julien P, Perron P, Hudson TJ, Vohl MC, Gaudet D (2002)
Pharmacogenetics
12 :313